BSE Limited, Asia’s oldest stock exchange, announced its unaudited consolidated financial results for Q3FY18 on Friday.

The PAT for the quarter came in at Rs. 25.94 crore, yoy decline of 66.4 per cent. This was also due to rise in effective tax rate to ~45 per cent from 34.4 per cent in Q3FY17.

Following stocks are close to their 52-week low as at 12.54 p.m. on February 2.

The markets on February 2 opened gap down. BSE Sensex is trading at 35,335.86, down by 570.80 points and the Nifty is trading at 10,850.40, down by 166.50 points.

Vakrangee is on a selling spree in the markets since January 29. The free fall in the company's stock price was in the wake of possible investigation by SEBI for suspected share price and volume manipulation. the stock formed a kind of Shooting Star pattern at all-time high.

The government’s 10-year bond yields are rising in the last couple of months. Read on to find out how this is going to impact the stock market. 

Pharma major Lupin on Thursday announced receiving final nod from the US Food and Drug Administration (USFDA) to market its Clobetasol Propionate cream.

Benchmark indices were in a sea of red, down close to 600 points on Friday. BSE Sensex was at 35,322.45, down by 584.21 or 1.63 per cent, Nifty50 was at 10,834.40, down by 182.50 or 1.66 per cent at around 10:30 hours. Markets seem to be extremely disappointed by the Union Budget 2018.